Skip to main content
OpenTrials

Clinical trial condition

Immune Sensitive Tumor

Explore clinical trials studying Immune Sensitive Tumor. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Immune Sensitive Tumor trial results

Recruiting

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

NCT06952010

Conditions
Advanced Solid Tumor, Immune Sensitive Tumor, Metastatic Solid Tumor, +6 more
Locations
  • Exelixis Clinical Site #5 San Francisco, California, United States
  • Exelixis Clinical Site #4 New Haven, Connecticut, United States
  • Exelixis Clinical Site #8 Tampa, Florida, United States
  • Exelixis Clinical Site #10 Boston, Massachusetts, United States
View Trial Details

Related conditions